Webinar: Bioanalysis of anti-body drug conjugates
Check out our 15-minute presentation on the revolutionary impact of ADCs in targeted cancer therapy. Detailing their journey from conception to becoming a leading treatment modality, we highlight the significant bioanalytical challenges and regulatory milestones that shape ADC development.
What you will learn:
- The components of ADCs and their roles in targeting and killing tumor cells
- Bioanalytical details on PK, PD, immunogenicity, receptor occupancy and immunotoxicity studies
- Analytical platforms and techniques
- Challenges in ADC bioanalysis
- Guidelines and strategies for biomarker bioanalysis
This content has been provided by WuXi AppTec. Check them out on X and LinkedIn
In association with:
